Bringing the fundamentals into focus…
Back to Anbio Biotechnology
How Anbio Biotechnology stacks up
NNNN · against 147 other Healthcare companies of similar size
Growth
11/ 100
Near the bottom of its peers.
Ranked #123 of 148 · scores higher than 16% of peers
Bars: peers in each 10-point band of the growth score19 peers with a growth score of 10–19, including NNNN · Click a bar to see the companies
Why growth scores 11?
Weighted metrics compared with all Healthcare companies.Mainly because of its 3-year revenue growth, which is weaker than most Healthcare peers.
- slower revenue growth over three years: weaker than 96% of peers. 3-year revenue growth: -28.4% vs peer median 5.8%
- Revenue growth is close to the peer norm. Revenue growth: 5.6% vs peer median 6.1%
- Earnings per share growth is not reported, so it is left out of the score.
Metric by metric
Position: dot = NNNN, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | NNNN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 158 reported | 5.6% | 4.0% | 55% | 33% | |
| Earnings per share growthHigher is better · 58 reported | Not reported | 1.8% | — | — | 33% |
| 3-year revenue growthHigher is better · 145 reported | -28.4% | 4.3% | 5% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around NNNN| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 1 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 1 | 592M ILS (≈$160M) | 99 | 84 | |
| 1 | 90M USD | 99 | 27 | |
| 1 | 97M USD | 99 | 63 | |
| 120 | 4.5B TWD (≈$138M) | 13 | 62 | |
| 121 | 1.4B HKD (≈$181M) | 12 | 61 | |
| 121 | 1.5B CNY (≈$205M) | 12 | 39 | |
| 123 | 326.5B KRW (≈$235M) | 11 | 52 | |
| 123 | 157M USD | 11 | ||
| 125 | 7.1B TWD (≈$221M) | 10 | 25 | |
| 125 | 158M USD | 10 | 14 | |
| 125 | 113M USD | 10 | 23 | |
| 128 | 1.8B CNY (≈$255M) | 9 | 29 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score